-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Axsome Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2015 to Q1 2024.
- Axsome Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$53.5M, a 819% decline year-over-year.
- Axsome Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$145M, a 24.5% decline from 2022.
- Axsome Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$117M, a 7.66% decline from 2021.
- Axsome Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$108M, a 37.9% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)